Status:

COMPLETED

A Drug-Drug Interaction (DDI) Study of ADC189 With Itraconazole in Healthy, Adult Subjects

Lead Sponsor:

Jiaxing AnDiCon Biotech Co.,Ltd

Conditions:

Healthy Adults

Eligibility:

All Genders

18-55 years

Phase:

PHASE1

Brief Summary

This study aims to answer how repeat doses of itraconazole impact the pharmacokinetics, safety, and tolerability of single doses of ADC189 in healthy adults. Participants in this study will complete ...

Eligibility Criteria

Inclusion

  • Sign informed consent, be capable of and willing to comply with study restrictions and procedures.
  • Healthy adult subjects aged 18 to 55 years.
  • Weight \>=50kg for males, and \>=45kg for females, BMI 19-26 kg/m\^2.
  • No clinical significance in physical examination, vital signs, laboratory examination, 12-lead electrocardiogram, abdominal ultrasound, and chest X-ray examination.

Exclusion

  • Subjects who participated in other drug trials within 3 months before screening
  • Hospital admission or major surgery within 4 weeks prior to screening or a preplanned hospital admission during study participation
  • Donated or lost ≥400 mL of blood in the previous 3 months before screening
  • Have a history of allergic diseases (asthma, urticaria, eczema, etc.), or food allergies
  • A history of drug abuse in the past five years
  • Any condition or finding that in the Investigator's opinion would put the participant or study conduct at risk if the participant were to participate in the study
  • Unable to complete this study for other reasons or the Investigator believes that he or she should be excluded

Key Trial Info

Start Date :

July 16 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 11 2024

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT06589635

Start Date

July 16 2024

End Date

September 11 2024

Last Update

January 20 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The First Affilicated Hospital of Bengbu Medical University

Bengbu, Anhui, China, 233004

A Drug-Drug Interaction (DDI) Study of ADC189 With Itraconazole in Healthy, Adult Subjects | DecenTrialz